These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9424585)

  • 1. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.
    Goodall AH; Knight C
    N Engl J Med; 1998 Jan; 338(2):130-1. PubMed ID: 9424585
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.
    Krulewitz A
    N Engl J Med; 1998 Jan; 338(2):130; author reply 131. PubMed ID: 9424584
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of low-molecular-weight heparin in unstable angina, acute myocardial infarction and post-elective percutaneous transluminal coronary angioplasty].
    Pimentel Filho WA
    Arq Bras Cardiol; 1995 Dec; 65(6):517-8. PubMed ID: 8731307
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-molecular-weight heparins for the treatment of acute coronary syndromes.
    Wong GC; Giugliano RP
    Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.
    Kearon C
    N Engl J Med; 1998 Jan; 338(2):129-30; author reply 131. PubMed ID: 9424582
    [No Abstract]   [Full Text] [Related]  

  • 6. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparins for acute coronary syndrome: tackling the issues head-on.
    Antman EM
    Am Heart J; 2003 Aug; 146(2):191-3. PubMed ID: 12891179
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Fernandez JS; Sadaniantz A
    Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.
    Baker BA; Adelman MD
    N Engl J Med; 1998 Jan; 338(2):130; author reply 131. PubMed ID: 9424583
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery disease.
    Husted S; Kher A
    Ann Med; 2000 Dec; 32 Suppl 1():53-9. PubMed ID: 11209983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparins better than unfractionated heparin in unstable coronary artery disease? Unstable angina pectoris/non-Q wave infarction a partly outpatient clinic condition?
    Kauw FH; Cleophas TJ; Kalmansohn RB
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):392-7. PubMed ID: 9707355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparins in the treatment of unstable angina.
    Ageno W; Turpie AG
    Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of low-molecular-weight heparin in acute coronary syndromes].
    Gharbi M; Barakett N; Lahidheb DH; Smiri Z; Fehri W; Azzouzi F; Rahal N; Mhenni H; Haouala H; Guediche M
    Tunis Med; 2002 Dec; 80(12):725-32. PubMed ID: 12664498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events.
    Demers C
    Can J Cardiol; 1998 Aug; 14 Suppl E():15E-19E. PubMed ID: 9779028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina].
    Godoy I; Herrera C; Zapata C; Kunstmann S; Abufhele A; Corbalán R
    Rev Med Chil; 1998 Mar; 126(3):259-64. PubMed ID: 9674294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin: an antithrombotic agent whose time has come.
    Futterman LG; Lemberg L
    Am J Crit Care; 1999 Jan; 8(1):520-3. PubMed ID: 9987551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-fractionated heparin versus low molecular weight heparin in acute coronary syndromes].
    González Pacheco H
    Arch Cardiol Mex; 2001; 71 Suppl 1():S63-8. PubMed ID: 11565348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of thrombin and its inhibition in unstable angina. Nonfractionated heparin, hirudin and defractionated heparins].
    López-Sendón J; López de Sá E; Rubio Sanz R; Delcán Domínguez JL
    Rev Esp Cardiol; 1999; 52 Suppl 1():76-89. PubMed ID: 10364817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation committees' methods for appraising new drugs. Committee failed to meet aims in producing report on low molecular weight heparins.
    Bosanquet N; Fox K
    BMJ; 2000 Mar; 320(7236):714-5. PubMed ID: 10710594
    [No Abstract]   [Full Text] [Related]  

  • 20. Unfractionated and low-molecular-weight heparins in acute coronary syndromes: current recommendations.
    Brener SJ
    Cleve Clin J Med; 2000 Jan; 67(1):59-65. PubMed ID: 10645678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.